Cleared Special

K170966 - TONOPORT VI

K170966 is an FDA 510(k) clearance for TONOPORT VI, manufactured by Par Medizintechnik GmbH & Co. KG. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Special 510(k) pathway after a 75-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
75d
Days
Class 2
Risk

K170966 is an FDA 510(k) clearance for the TONOPORT VI. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Par Medizintechnik GmbH & Co. KG (Berlin, DE). The FDA issued a Cleared decision on June 14, 2017 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Par Medizintechnik GmbH & Co. KG devices

FDA 510(k) Submission Details - K170966

510(k) Number K170966 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2017
Decision Date June 14, 2017
Days to Decision 75 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 125d · This submission: 75d
Pathway characteristics
Modification to existing cleared device.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 840
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K170966.
Electronic Blood Pressure Monitor
K161845 · Shenzhen Pango Electronic Co., Ltd. · Jul 2017
Fully Automatic Blood Pressure Monitor
K171282 · Andon Health Co, Ltd. · Jul 2017
Digital Automatic Blood Pressure Monitor BPM41 Series, Digital Automatic Blood Pressure Monitor BPM45 Series
K163648 · Grandway Technology (Shenzhen) Limited · Jul 2017
Digital Automatic Blood Pressure Monitor MD3600
K163679 · Grandway Technology (Shenzhen) Limited · Jun 2017
Matrix Data Management System
K162463 · Global Instrumentation, LLC · May 2017
A&D Medical UB-1100BLE UltraConnect Digital Blood Pressure Monitor
K170196 · A&D Company, Ltd. · May 2017